201 related articles for article (PubMed ID: 28682542)
21. The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation.
Boström EA; Lundberg P
PLoS One; 2013; 8(12):e81665. PubMed ID: 24339952
[TBL] [Abstract][Full Text] [Related]
22. Collinin reduces Porphyromonas gingivalis growth and collagenase activity and inhibits the lipopolysaccharide-induced macrophage inflammatory response and osteoclast differentiation and function.
Santos J; Marquis A; Epifano F; Genovese S; Curini M; Grenier D
J Periodontol; 2013 May; 84(5):704-11. PubMed ID: 22897650
[TBL] [Abstract][Full Text] [Related]
23. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
24. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM; Nishioka K; Yudoh K
Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
[TBL] [Abstract][Full Text] [Related]
25. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
[TBL] [Abstract][Full Text] [Related]
26. The molecular basis of osteoclast differentiation and activation.
Suda T; Kobayashi K; Jimi E; Udagawa N; Takahashi N
Novartis Found Symp; 2001; 232():235-47; discussion 247-50. PubMed ID: 11277084
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism.
Zou W; Hakim I; Tschoep K; Endres S; Bar-Shavit Z
J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):70-83. PubMed ID: 11500955
[TBL] [Abstract][Full Text] [Related]
28. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
29. TBK1 mediates critical effects of measles virus nucleocapsid protein (MVNP) on pagetic osteoclast formation.
Sun Q; Sammut B; Wang FM; Kurihara N; Windle JJ; Roodman GD; Galson DL
J Bone Miner Res; 2014 Jan; 29(1):90-102. PubMed ID: 23794264
[TBL] [Abstract][Full Text] [Related]
30. A signal through 4-1BB ligand inhibits receptor for activation of nuclear factor-kappaB ligand (RANKL)-induced osteoclastogenesis by increasing interferon (IFN)-beta production.
Shin HH; Lee EA; Kim SJ; Kwon BS; Choi HS
FEBS Lett; 2006 Mar; 580(6):1601-6. PubMed ID: 16480981
[TBL] [Abstract][Full Text] [Related]
31. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
32. Bee venom attenuates Porphyromonas gingivalis and RANKL-induced bone resorption with osteoclastogenic differentiation.
Gu H; An HJ; Kim JY; Kim WH; Gwon MG; Kim HJ; Han SM; Park I; Park SC; Leem J; Park KK
Food Chem Toxicol; 2019 Jul; 129():344-353. PubMed ID: 31055000
[TBL] [Abstract][Full Text] [Related]
33. The hemoglobin receptor protein of porphyromonas gingivalis inhibits receptor activator NF-kappaB ligand-induced osteoclastogenesis from bone marrow macrophages.
Fujimura Y; Hotokezaka H; Ohara N; Naito M; Sakai E; Yoshimura M; Narita Y; Kitaura H; Yoshida N; Nakayama K
Infect Immun; 2006 May; 74(5):2544-51. PubMed ID: 16622189
[TBL] [Abstract][Full Text] [Related]
34. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
[TBL] [Abstract][Full Text] [Related]
35. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
36. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
[TBL] [Abstract][Full Text] [Related]
37. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
38. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.
Jimi E; Akiyama S; Tsurukai T; Okahashi N; Kobayashi K; Udagawa N; Nishihara T; Takahashi N; Suda T
J Immunol; 1999 Jul; 163(1):434-42. PubMed ID: 10384146
[TBL] [Abstract][Full Text] [Related]
39. Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production.
Ukai T; Yumoto H; Gibson FC; Genco CA
Infect Immun; 2008 Feb; 76(2):812-9. PubMed ID: 17998311
[TBL] [Abstract][Full Text] [Related]
40. RANKL pretreatment plays an important role in the differentiation of pit-forming osteoclasts induced by TNF-α on murine bone marrow macrophages.
Yamashita Y; Ukai T; Nakamura H; Yoshinaga Y; Kobayashi H; Takamori Y; Noguchi S; Yoshimura A; Hara Y
Arch Oral Biol; 2015 Sep; 60(9):1273-82. PubMed ID: 26099662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
